![](/img/cover-not-exists.png)
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada
Stephanie R. Earnshaw, Yola Moride, Sophie RochonVolume:
29
Year:
2007
Language:
english
Pages:
2107
DOI:
10.1016/j.clinthera.2007.09.001
File:
PDF, 1.71 MB
english, 2007